Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: PPD DEVELOPMENT LP
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-09-11 to 2026-11-15
Current total value of award: $724461
Description: FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE